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Abstract
Background: Proper execution of chromosome segregation relies on tight control of attachment of chromosomes to
spindle microtubules. This is monitored by the mitotic checkpoint that allows chromosome segregation only when all
chromosomes are stably attached. Proper functioning of the attachment and checkpoint processes is thus important to
prevent chromosomal instability. Both processes rely on the mitotic kinase Mps1.
Principal Finding: We present here two cell lines in which endogenous Mps1 has been stably replaced with a mutant kinase
(Mps1-as) that is specifically inhibited by bulky PP1 analogs. Mps1 inhibition in these cell lines is highly penetrant and
reversible. Timed inhibition during bipolar spindle assembly shows that Mps1 is critical for attachment error-correction and
confirms its role in Aurora B regulation. We furthermore show that Mps1 has multiple controls over mitotic checkpoint
activity. Mps1 inhibition precludes Mad1 localization to unattached kinetochores but also accelerates mitosis. This
acceleration correlates with absence of detectable mitotic checkpoint complex after Mps1 inhibition. Finally, we show that
short-term inhibition of Mps1 catalytic activity is sufficient to kill cells.
Conclusions/Significance: Mps1 is involved in the regulation of multiple key processes that ensure correct chromosome
segregation and is a promising target for inhibition in anti-cancer strategies. We report here two cell lines that allow specific
and highly penetrant inhibition of Mps1 in a reproducible manner through the use of chemical genetics. Using these cell
lines we confirm previously suggested roles for Mps1 activity in mitosis, present evidence for novel functions and examine
cell viability after short and prolonged Mps1 inhibition. These cell lines present the best cellular model system to date for
investigations into Mps1 biology and the effects of penetrance and duration of Mps1 inhibition on cell viability.
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Introduction
To maintain a stable genome, cells have evolved a variety of
processes that ensure accurate chromosome segregation. In early
mitosis, kinetochores of sister chromatids attach to microtubules
emanating from opposite spindle poles. Correct end-on attach-
ment of microtubules to kinetochores relies on the error-correction
machinery that destabilizes improper attachments through the
actions of the Aurora B kinase [1]. As long as unattached
kinetochores persist, the onset of anaphase is prevented by a
surveillance mechanism called the mitotic checkpoint that will halt
cell cycle progression until all chromosomes are stably attached to
the mitotic spindle [2]. The mitotic checkpoint will be satisfied
upon stable biorientation of all chromosomes, after which
chromosome segregation is allowed to proceed. Proper execution
of chromosome biorientation and mitotic checkpoint signaling
relies on a set of multifunctional kinases, one of which is the dual
specificity kinase Mps1 [3].
First discovered to regulate spindle pole body duplication in
budding yeast [4], Mps1 was subsequently found to additionally
regulate the mitotic checkpoint [5] and spindle assembly [6].
Regulation of the mitotic checkpoint by Mps1 is evolutionary
conserved and has been shown in fission yeast, fruit flies, Xenopus
egg extracts and human cells [7–11]. Mps1 exerts this control, at
least in part, through regulating kinetochore localization of several
checkpoint proteins including Mad1 and Mad2 [9,11,12].
Recently, Mps1 was also reported to regulate sister chromatid
biorientation in both budding yeast and humans [12,13]. In
human cells, Mps1 promotes biorientation by regulating Aurora B
activity through phosphorylation of the chromosomal passenger
complex (CPC) member Borealin [12,14].
Due to its central role in mitosis, misregulation of Mps1 kinase
activity results in chromosomal instability (CIN) and subsequent
aneuploidy, a hallmark shared by cells from solid tumors [15,16].
Inefficient activation of Mps1 results in weakened mitotic
checkpoint activity and the persistence of falsely attached
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segregation errors [16]. Conversely, reduction of Mps1 activity
has recently been shown to sensitize tumor cells but not normal
cells to low doses of taxol by elevating the frequency of
chromosome missegregations to near-lethal levels [17]. Partial
inhibition of Mps1 might therefore be an effective anti-cancer
therapy.
Although RNAi studies have uncovered several aspects of
human Mps1 biology, the multifunctional character of Mps1 has
prevented detailed and temporally controlled investigations into
the different roles Mps1 might play in mitosis. Inhibition using the
small molecules SP600125 and cincreasin has proved to be useful
[18,19], but cincreasin does not inhibit Mps1 in human cells [19]
and the non-specific nature of SP600125 makes it an unfavorable
choice to study Mps1. A more controlled approach is the use of
chemical genetics, in which endogenous kinase is replaced by an
engineered protein containing a mutated gatekeeper residue [20].
These gatekeeper mutants render the kinase specifically sensitive
to inhibition by non-hydrolysable bulky ATP analogs such as
chemically modified variants of the Src inhibitor PP1. This
approach has previously been described for Mps1 in budding yeast
[6,13] and in human cells in combination with transient RNAi
[21]. The use of transient RNAi, however, introduces uncertainties
regarding efficiency of knock down and reproducibility.
We present two cell lines in which endogenous Mps1 has been
stably replaced with gatekeeper mutants. In-depth analysis of these
clonal cell lines showed that addition of bulky PP1 analogs allowed
rapid and reversible inhibition of Mps1 kinase activity in a highly
penetrant and reproducible manner. Using these cell lines we
dissected the different roles of Mps1 in mitosis, further establishing
known functions in checkpoint regulation and error-correction
and providing novel insights in the function of Mps1 catalytic
activity in checkpoint regulation.
Results
Mps1 is selectively inhibitable in two engineered cell
lines
To study the role of Mps1 in different mitotic processes, we
created cell lines in which Mps1 kinase activity could specifically
and reversibly be inhibited. For this, we engineered the ATP-
binding pocket of Mps1 to create a kinase with unique preference
for bulky ATP-like small molecules [20]. As previously shown for
Mps1 in a transient expression system [21], Mps1
M602A signifies
such an analog sensitive (as) version. In addition to M602A, we
also tested M602G, which similarly enlarges the ATP-binding
pocket of Mps1 and may provide stronger inhibition [6]. To
ensure that mutation of the gatekeeper residue did not affect Mps1
functionality, the ability of both Mps1
M602A and Mps1
M602G to
sustain an active checkpoint in Mps1 RNAi cells was investigated.
Similar to LAP-Mps
WT, both LAP-Mps1
M602A and LAP-
Mps1
M602G reconstituted checkpoint signaling in response to
nocodazole when endogenous Mps1 was transiently replaced with
these proteins (Fig. S1A).
To create stable cell systems in which Mps1 could be inhibited
in a potent and reproducible manner, we stably expressed LAP-
Mps1
M602A (hereafter referred to as Mps1
as) or LAP-Mps1
M602G
in UTRM10 (U2OS-derived) and HCT-TRM (HCT116-derived)
cell lines in which endogenous Mps1 could be removed by
doxycycline-induced expression of Mps1 shRNA [17]. Continuous
growth in doxycycline and clonal selection resulted in stable, viable
clonal cell lines in which endogenous Mps1 was undetectable and
replaced with Mps1
WT or Mps1
as (Fig. 1A). No HCT-TRM clones
expressing Mps1
M602G were obtained and only one such
UTRM10 clone grew out. We suspect that the low activity of
Mps1
M602G (see below) significantly decreased the chance of
survival of cells expressing only this form of Mps1. Nevertheless,
one UTRM10 cell line expressing Mps1
M602G was established,
showing that under certain circumstances, Mps1
M602G can
support viability. All cell clones (renamed HCT-Mps1
WT, HCT-
Mps1
as, UTR-Mps1
WT, UTR-Mps1
as and UTR-Mps1
M602G)
have been kept in culture for months, showing that replacement
of Mps1 is stable.
Human Mps1 auto-activates by phosphorylating T676 in its
activation loop. T676 phosphorylation is essential for full kinase
activity [16,22,23], and the phosphorylation status of T676 serves
as a read-out for Mps1 kinase activity [16]. To investigate if
Mps1
as activity could be inhibited by bulky PP1 analogs in our
engineered cell lines, we examined Mps1 T676 phosphorylation in
different conditions. Following tests on the potency of different
PP1 analogs to inhibit Mps1
as (Fig. S1B), we settled on 23dMB-
PP1 (1-(tert-butyl)-3-(2,3-dimethylbenzyl)-1H-pyrazolo[3,4-d]pyri-
midin-4-amine) as the Mps1
as inhibitor of choice. As expected,
Mps1
WT and Mps1
as displayed a mobility shift and phosphory-
lation of T676 upon nocodazole addition in both HCT and UTR
cell types (Fig. 1B). Whereas addition of 23dMB-PP1 did not affect
the mobility or T676 phosphorylation of Mps1
WT, 23dMB-PP1
prevented hyperphosphorylation as well as T676 phosphorylation
of Mps1
as (Fig. 1B). Full inhibition of Mps1
as was established
within 5 minutes after addition of 23dMB-PP1 (Fig. 1C). Further-
more, T676 phosphorylation could be detected 15 minutes after
removal of 23dMB-PP1, showing that this rapid inhibition was
reversible (Fig. 1D). Interestingly, very little T676 phosphorylation
and weak mobility shift was detected in the UTR-Mps1
M602G
clone, indicating this engineered Mps1 kinase has strongly reduced
activity compared to Mps1
WT and Mps1
as (Fig. S2A). Although
any residual activity and all Mps1 functions could be efficiently
inhibited by treatment of the UTR-Mps1
M602G cells with PP1
inhibitors (Fig. S2 and S3B), we focused our investigations on
studies with the Mps1
as clones.
Mps1
as inhibition by 23dMB-PP1 disables mitotic
checkpoint signaling
Mps1 kinase activity is needed for the mitotic checkpoint to
delay mitosis when unattached kinetochores persist [6,9,12,18,21].
We next studied the ability of the cell lines to maintain a mitotic
checkpoint response in the presence of 23dMB-PP1. In absence of
23dMB-PP1, all HCT-Mps1
WT and HCT-Mps1
as cell lines
sustained checkpoint activity in the presence of nocodazole as
scored by mitotic index (Fig. 2A). The ability to maintain a
nocodazole-induced mitotic delay was not lost in Mps1
WT cells
upon treatment with 23dMB-PP1, showing 23dMB-PP1 did not
have off-target effects that could disable the mitotic checkpoint. In
contrast to Mps1
WT-expressing cells, 23dMB-PP1 completely
abolished mitotic checkpoint activity in Mps1
as cells. Similar
results were obtained with the UTR-Mps1
M602G cells (Fig. S2B).
To ensure that Mps1 inhibition decreased mitotic index by
inhibiting mitotic checkpoint activity rather than, for instance,
preventing entry into mitosis, mitotic progression in the presence
of spindle poisons was monitored by live cell differential
interference contrast (DIC) microscopy. As a measure for time
spent in mitosis, the time from nuclear envelope breakdown (NEB)
to the first signs of furrow ingression was scored. Engaging the
mitotic checkpoint in these cells by treatment with the spindle
drugs nocodazole or taxol, or the Eg5 inhibitor STLC caused all
cell lines to delay mitosis for hours (Fig. 2B–F and S3). Delays were
most pronounced in cells with the HCT-TRM background where
,95% of cells maintained the arrest for at least 4 hours (Fig. 2C,
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In stark contrast, addition of 23dMB-PP1 caused all HCT-Mps1
as
but not HCT-Mps1
WT cells to exit mitosis within 60 minutes
(Fig. 2D and S3A, C). These data show that the ability of cells to
delay mitotic progression absolutely requires Mps1 kinase activity.
Moreover, the finding that all 23dMB-PP1-treated HCT-Mps1
as
cells had lost this ability illustrated the clonality of this cell line.
Mps1 kinase activity promotes localization of Mad1,
Mad2, Cdc20 and Bub1 to unattached kinetochores
Proper functioning of the mitotic checkpoint requires the
recruitment of checkpoint proteins to the kinetochore. Kinase
activity of Mps1 is required for the recruitment of Mad2 to
unattached kinetochores, at least partly explaining its necessity for
checkpoint signaling [9,12,21]. There is, however, discrepancy
between reports on the requirement of Mps1 for the recruitment of
Mad1 [11,12,21,24], Bub1 [11,12,24,25], BubR1 [11,12,18,23]
and CENP-E [9,12,21,24,26] to kinetochores.
To examine how Mps1 catalytic activity contributes to
recruitment of these and other checkpoint proteins, we assayed
their kinetochore association after inhibition of Mps1
as in our cell
lines. Like the ability to delay mitosis, kinetochore recruitment of
Mad1, Mad2, BubR1, Bub1, CENP-E and Cdc20 was altered
neither in DMSO-treated Mps1
WT or Mps1
as cells, nor in 23dMB-
PP1-treated Mps1
2WT cells (Fig. 3 and S4). However, addition of
23dMB-PP1 to Mps1
as cells significantly reduced the level of
Mad1, Mad2, Bub1 and Cdc20 at unattached kinetochores, but
only marginally affected BubR1 levels and did not influence
CENP-E levels (Fig. 3). These data show that Mps1 kinase activity
promotes kinetochore-binding of Mad1, Mad2, Bub1 and Cdc20.
Mps1 inhibition strongly diminishes MCC levels in mitotic
cells
The mitotic checkpoint functions through the production of an
inhibitory complex called the mitotic checkpoint complex (MCC).
The MCC targets Cdc20, the main activator of the anaphase
promoting complex or cyclosome (APC/C) in prometaphase,
thereby preventing exit from mitosis [2]. The amplification of
MCC assembly by unattached kinetochores is dependent on
kinetochore localization of Mad1 and Mad2 [27,28]. Since
inhibition of Mps1 resulted in loss of kinetochore-bound Mad1/
Mad2, we set out to investigate if Mps1 inhibition influences the
amount of MCC in nocodazole-treated cells. As expected, Cdc20
immunoprecipitations from cells treated with DMSO contained
the MCC subunits Mad2, BubR1 and Bub3 (Fig. 4A). Although
inhibition of Mps1 did not alter the levels of coprecipitated BubR1
and Bub3, the amount of Cdc20-bound Mad2 in mitotic cells was
reduced to interphase levels after treatment with 23dMB-PP1
Figure 1. Stable expression of LAP-Mps1
as renders selective sensitivity to 23dMB-PP1. A: Mps1 and tubulin immunoblots of lysates of
UTRM10 and HCT-TRM cells in which endogenous Mps1 is removed by doxycycline-induced expression of Mps1 shRNA and replaced with the
indicated LAP-Mps1 mutants. B–D: pT676-Mps1 and Mps1 immunoblots of UTR-Mps1
as (B) and HCT-Mps1
as (B–D) cell lines treated with nocodazole
and MG132 in combination DMSO/23dMB-PP1 for 1 hour (B), with nocodazole and MG132 for 1 hour in combination with an additional 23dMB-PP1
treatment for the indicated amounts of time (C), or with nocodazole and MG132 in combination with 23dMB-PP1 for 1 hour, followed by PBS wash
after which cells were left for 15 or 30 minutes in media without 23dMB-PP1 (D).
doi:10.1371/journal.pone.0010251.g001
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bound Cdc20 in cells treated with 23dMB-PP1 when compared to
DMSO-treated cells (Fig. 4B). These data show that Mps1
catalytic activity is needed for formation and/or stability of MCC.
Mps1 inhibition decreases the time spent in mitosis
To get more detailed insight in the functions of Mps1 kinase
activity during mitosis, we examined various aspects of chromo-
some segregation in our cell lines by time-lapse microscopy.
Mps1
WT cells treated with DMSO or 23dMB-PP1 progressed
through mitosis normally. In addition, 23dMB-PP1 treatment of
Mps1
as-expressing cells caused no overt problems in mitotic entry,
bipolar spindle formation or cytokinesis in neither cell line.
Strikingly, however, 23dMB-PP1-treated Mps1
as cells sped
through mitosis (Fig. 5A). To more carefully quantify this
phenotype, the time from NEB to the first signs of furrowing
Figure 2. Mps1 activity is essential for the mitotic checkpoint. A: Quantification of flow cytometric analysis of the fraction of mitotic cells
treated with DMSO or 23dMB-PP1 alone or in combination with nocodazole for 14 hours. Graph represents average of three experiments (+/2SD). B–
F: Time-lapse analysis by DIC microscopy of HCT- and UTR-derived cells treated with taxol (HCT-derived cells) or STLC (UTR-derived cells) in
combination with DMSO or 23dMB-PP1. Images in B display morphology of HCT-Mps1
as cells imaged at the indicated timepoints after addition of
taxol in combination with DMSO or 23dMB-PP1. Graphs in C and E represent percentages of cells delayed in mitosis for 4 hours or longer.
Percentages are indicated at top of each column. Line graphs in D and F show cumulative percentages of cells that display first signs of furrowing at
indicated times after NEB. Dashed lines indicate half-time to furrowing of inhibited drug-treated Mps1
as cells.
doi:10.1371/journal.pone.0010251.g002
Chemical Genetics of Mps1
PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e10251was measured. Half of DMSO-treated HCT-Mps1
WT and HCT-
Mps1
as cells had proceeded to furrow ingression 26 and
22 minutes after NEB, respectively (Fig. 5B). Strikingly, whereas
addition of 23dMB-PP1 had no effect on the time to furrow
ingression of HCT-Mps1
WT cells, half the 23dMB-PP1-treated
HCT-Mps1
as cells showed signs of furrow ingression in as little as
10 minutes and no cell took longer than 20 minutes to reach this
furrowing stage of mitosis (Fig. 5A, B). Further evidence for the
high penetrance of Mps1 inhibition in these cells was illustrated by
the fact that exit from mitosis in taxol was within a similar
Figure 3. Mps1 kinase activity promotes localization of Mad1, Mad2, Bub1 and Cdc20 to unattached kinetochores. A, B:
Immunolocalization of Mad1, Mad2, Bub1, BubR1, CENP-E, Cdc20, and centromeres (ACA) in HCT-derived (A) or UTR-derived (B) cells treated with
nocodazole and MG132 for 1 hour in combination with DMSO or 23dMB-PP1. Graphs represent quantifications of kinetochore signal intensities for
the investigated proteins at all kinetochores in a single cell as a ratio of the ACA signal. Data are average of three experiments, 10 cells per experiment
(+/2 SD). Representative images are shown.
doi:10.1371/journal.pone.0010251.g003
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respectively (Fig. 2D). A similar, albeit less consistent effect was
apparent in the UTR-derived cell lines: Half-time to furrowing in
UTR-Mps1
as cells was reduced from 18 to 12 minutes by
treatment with 23dMB-PP1, whereas this was not altered by
23dMB-PP1 in UTR-Mps1
WT cells (Fig. 5C).
Mps1 activity facilitates attachment error-correction
Mps1 is critical for chromosome biorientation in yeast and
humans [12,13] and our previous results using Mps1 RNAi
supported the hypothesis that Mps1 facilitates error-correction by
promoting Aurora B activity at inner centromeres [12]. Never-
theless, a true display of the role for Mps1 in error-correction
requires inhibition of Mps1 activity solely during the error-
correction process. Our analog-sensitive cell lines provided the
opportunity to test this. We first verified that Mps1 inhibition
prevented efficient chromosome alignment on the cell’s equator.
Cells were treated with MG132 for 60 minutes to prevent exit
from mitosis and provide cells with sufficient time to align all
chromosomes. Roughly 30% of DMSO- or 23dMB-PP1-treated
HCT-Mps1
WT cells or DMSO-treated HCT-Mps1
as cells dis-
played misaligned chromosomes within this time (Fig. 6A). In
agreement with our previous studies [12], addition of 23dMB-PP1
to HCT-Mps1
as cells caused severe alignment problems in ,70%
of cells. Similar results were obtained by Mps1 inhibition in UTR-
Mps1
M602G cells (Fig S2C).
We next investigated if the generated cells lines were able to
correct faulty attachments when Mps1 was inhibited during
error-correction rather than prior to the establishment of errors.
To this end, cells were treated with the Eg5-inhibitor monastrol
to create monopolar spindles with large numbers of chromo-
somes that have syntelic or monotelic attachments [29].
Monastrol can efficiently be removed from cell, which allows
the formation of a bipolar spindle in which full chromosome
alignment requires correction of the improper attachments by
Aurora B [30,31]. All attachment errors were corrected and full
chromosome alignment was restored in 87% of HCT-Mps1
WT
cells 50 minutes after removal of monastrol (Fig. 6B, C).
Addition of 23dMB-PP1 during monastrol washout of Mps1
as
cells however, caused significant problems with chromosome
alignment (Fig. 6B, C). Importantly, the non-aligned chromo-
somes were often seen to have retained syntelic attachments,
indicative of error-correction deficiency. These data solidify the
notion that Mps1 activity is needed for efficient correction of
erroneous attachments.
Mps1 enhances Aurora B activity
Erroneous kinetochore-microtubule attachments cause a lack
of tension between sister centromeres which allows Aurora B
kinase activity to destabilize such attachments [31–36]. We and
others previously found that Mps1 enhances Aurora B activity
up to 4-fold by phosphorylating the CPC component Borealin,
explaining the contribution of Mps1 to error-correction
[12,14]. We next set out to examine the link between Mps1
and Aurora B activity in our analog-sensitive cell lines. Using
phosphate-affinity gel electrophoresis [37], Borealin displayed a
prominent mobility shift in mitotic samples of nocodazole-
treated cells (Fig. 6D). This shift was reduced upon inhibition of
Mps1
as by 23DMB-PP1, showing for the first time that
phosphorylation of endogenous Borealin is under control of
Mps1 activity.
To investigate the consequences of Mps1 inhibition on Aurora
B activity, mitotic cells were collected by shake-off after 14 hours
of taxol treatment and subsequently treated with 23dMB-PP1 or
DMSO in combination with MG132 for an additional hour, after
which mitotic lysates were examined for phosphorylation of Serine
10 in Histone H3 (pS10-H3) by immunoblot. Surprisingly,
addition of 23dMB-PP1 to UTR- or HCT-Mps1
as cells that had
been arrested in mitosis for hours did not significantly reduce
pS10-H3, even though Mps1 activity, as measured by mobility
shift, was inhibited (Fig 6E, F). These findings are in seeming
contrast to our previous report, in which Mps1 RNAi reduced
Figure 4. Mps1 inhibition reduces Mad2-Cdc20 interaction. A, B: Immunoblots of the indicated proteins in immunoprecipitations of Cdc20 (A)
or Mad2 (B). Immunoprecipitations were preformed on interphase cell lysates (thymidine, thy) or mitotic cell lysates (nocodazole, noco) of HCT-
Mps1
as cells treated with DMSO or 23dMB-PP1 in combination with MG132 for 1 hour. Quantification of Mad2 levels in Cdc20 immunoprecipitates,
relative to interphase levels, is indicated in A, right panel.
doi:10.1371/journal.pone.0010251.g004
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these experiments is whether or not cells entered mitosis with
intact Mps1 activity, we next examined pS10-H3 levels in cells that
had seen 23dMB-PP1 prior to mitotic entry. For this, cells were
treated with DMSO or 23dMB-PP1 for 1 hour, after which taxol/
MG132 was added for an additional 2 hours. Analysis of these
mitotic samples showed significant reduction of pS10-H3 levels in
23dMB-PP1-treated Mps1
as cells but not Mps1
WT cells (Fig. 6E, F
and S5). The magnitude of this decrease is less prominent than
direct inhibition of Aurora B activity using ZM447439 (Fig. 6E, F
and S5) [33], which is in line with our previous observations that
showed that while Mps1 could enhance Aurora B activity, it was
not absolutely critical [12].
Selective, short-term inhibition of Mps1 kills cells
Long-term Mps1 RNAi kills U2OS, HCT116 and LS174T
cells [16,17] and Mps1 inhibition has been proposed as an
effective way to induce a lethal dose of chromosome segregation
errors [17,38,39]. To examine if selective and penetrant
inhibition of the catalytic activity of Mps1 is lethal, UTR- and
HCT-derived Mps1
wt and Mps1
as cells were treated with
23dMB-PP1 for 8 days after which colony outgrowth was
scored. 23dMB-PP1 had no off-target effect on viability during
this period, as Mps1
wt cells remained fully viable despite
prolonged exposure to 23dMB-PP1 (Fig. 7A). As shown in
F i g .7 B ,h o w e v e r ,n oM p s 1
as cells survived prolonged Mps1
inhibition. To approach a more relevant duration of inhibition
in potential future clinical settings, we next tested the effect of
short-term inhibition of Mps1 on cell viability. Addition of
23dMB-PP1 for 2 days and subsequent removal of the inhibitor
until day 8 left no (HCT-Mps1
as) or very few (UTR-Mps1
as)
cells alive (Fig. 7B). These data show that efficient inhibition
of Mps1 for a relatively short period of time is sufficient to kill
cells.
Figure 5. Mps1 inhibition accelerates mitosis. A–C: Time-lapse analysis by DIC microscopy of mitotic progression of HCT-derived (A, B) and UTR-
derived (C) cells treated with DMSO or 23dMB-PP1. Images in A display morphology of HCT-derived cells imaged at the indicated timepoints after
NEB (nuclear envelope breakdown). Graphs in B and C show cumulative percentages of cells that display first signs of furrowing at indicated times
after NEB. Dashed lines indicate half-time to furrowing.
doi:10.1371/journal.pone.0010251.g005
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In the present study we investigated the different roles of Mps1
in mitosis of human cells through the use of chemical genetics. We
report here two clonal cell lines expressing analog-sensitive
versions of Mps1 in which endogenous Mps1 was stably removed
by doxycycline-induced shRNA expression. Use of these cell lines
circumvents experimental limitation in reproductivity and pene-
trance associated with transient RNAi reconstitutions [21] and
allows temporal control of Mps1 activity.
Chemical genetic inhibition of Mps1 was previously used to
uncover novel aspects of Mps1 in S. cerevisiae mitosis [6,13]. A yeast
strain carrying the analog-sensitive M516G mutation (similar to
the M602G mutation in human Mps1, included in the present
study) allowed analysis of Mps1 functions after the moment of
spindle pole body duplication, a critical function of Mps1 in
budding yeast [4,6]. Using this strain (mps1-as1), it was verified that
Mps1 inhibition prevents mitotic checkpoint activity and causes
cell death [6]. In addition, Mps1-inhibited yeast cells were found
to display spindle morphology defects and chromosome misposi-
tioning [6], possibly as a consequence of errors in chromosome
biorientation [13].
In agreement with these and other reports [6,12,13], chemical
genetic inhibition of Mps1 in our human cell lines verified that
Mps1 kinase activity is critical for chromosome biorientation.
Although our data using Mps1 RNAi supported the hypothesis
that Mps1 facilitated error-correction by promoting Aurora B
activity at inner centromeres [12], we now show that error-
correction is also prevented when Mps1 kinase activity is inhibited
only during the error-correction process in cells undergoing
spindle bipolarisation after monastrol wash-out. Additionally,
through the use of phosphate-affinity gel electrophoresis we show
that phosphorylation of endogenous Borealin is under the control
of Mps1. Borealin phosphorylation enhances Aurora B activity
[12,14] yet inhibition of Mps1 did not affect pS10-H3 levels under
conditions that showed an increase in Borealin mobility. pS10-H3
was only found reduced when cells entered mitosis without Mps1
activity. These results suggest that partial reduction in Aurora B
activity caused by Mps1 inhibition is difficult to detect once pS10-
H3 is fully established, possibly because of low turnover of the
phosphate group on S10-H3. In support of this, inactivation of
Aurora B by a 2 hour exposure of our HCT-derived cells to
ZM447439 only caused a moderate reduction of pS10-H3 levels.
These data indicate that pS10-H3 serves as a good readout for
Mps1-dependent regulation of Aurora B activity when pS10-H3 is
not fully established at mitotic entry. Nevertheless, since Mps1
inhibition during mitosis affects Borealin phosphorylation and
error-correction, it is likely that acute effects on Aurora B activity
by Mps1 inhibition can be visualised with antibodies to the
relevant error-correction substrates.
The function of Mps1 kinase activity in the regulation of the
mitotic checkpoint has previously been established by various labs
including ours, and the present data fully agree with this
[6,9,12,18,21]. As expected [11,12,24], Mps1 inhibition in our
cell lines caused mislocalization of Mad1 and Mad2. This disagrees
with the study by Tighe et al., in which chemical genetic inhibition
of Mps1 in cells transiently transfected with Mps1 shRNA plasmids
had little effect on Mad1 recruitment [21]. This discrepancy may
be due to differences in penetrance of Mps1 inhibition. Whereas
inhibition of Mps1 with 1NM-PP1 in the Tighe et al. study left
mitotic progression unaffected in a large proportion of cells, mitosis
was disturbed in the vast majority (UTR-Mps1
as) or all (HCT-
Mps1
as) cells in our cell lines (Fig. 2 and 5). This difference in
penetrance may be due to inefficient RNAi by transient shRNA
transfection or potency of 1NM-PP1 in the Tighe et al., study. In
our hands, 1NM-PP1 was significantly less capable of inhibiting
Mps1 than 23dMB-PP1 or 3MB-PP1 (Fig. S2). Besides Mad1/
Figure 6. Mps1 activity is required for efficient correction of erroneous attachments. A: Chromosome alignment in HCT- and UTR-Mps1
WT
and -Mps1
as cell lines treated with MG132 for 60 minutes in combination with DMSO or 23dMB-PP1. Graphs display percentages of cells with
misaligned chromosomes, averages of three experiments, at least 50 mitotic cells per experiment (+/2SD). B, C: Immunostainings of HCT-Mps1
WT and
HCT-Mps1
as cells treated with monastrol for 30 min followed by a release from monastrol into MG132 with or without 23dMB-PP1 for 50 minutes.
Cells in B were immunostained for tubulin (green) and centromeres (ACA, red). DNA (DAPI) is in blue. Graph in C indicates the percentage of mitotic
cells with misaligned chromosomes 50 minutes after monastrol washout, averages of two experiments, at least 100 mitotic cells per experiment
(+/2SD). D: Immunoblots of Borealin after phosphate-affinity gel electrophoresis of lysates from nocodazole-treated HCT-Mps1
as cells to which DMSO
or 23dMB-PP1 and MG132 was added during the final hour. E, F: Immunoblots of the indicated proteins in lysates of the UTR- (E) and HCT-Mps1 (F)
variant cell lines. Cells were treated either with thymidine (thy), with taxol for 14 hours followed by the indicated inhibitors for an additional 2hrs, or
with the indicated inhibitors for 1 hour followed by taxol/MG132 treatment for an additional 2 hrs ZM, ZM447439. Arrow in F points to Cyclin B.
Asteriks indicates aspecific band in thymidine sample.
doi:10.1371/journal.pone.0010251.g006
Figure 7. Specific inhibition of Mps1 enzymatic activity causes
cell death. HCT-Mps1
WT and UTR-Mps1
WT cells (A) and HCT-Mps1
as
and UTR-Mps1
as cell (B) were treated with or without (-) 23dMB-PP1 for
8 days (8d), or with 23dMB-PP1 for 2 days (2d) followed by wash-out
and continued growth until day 8.
doi:10.1371/journal.pone.0010251.g007
Chemical Genetics of Mps1
PLoS ONE | www.plosone.org 9 April 2010 | Volume 5 | Issue 4 | e10251Mad2, our data further indicate that Mps1 is essential for
recruitment of Cdc20 as well as Bub1 to unattached kinetochores,
in agreement with some [11,25] but not other [12,24] previous
reports using Mps1 RNAi or Mps1 protein depletion.
Mps1 inactivation affects the quality of chromosome segregation
in unperturbed mitosis [16,21]. Using time-lapse microscopy we
show that inactivation of Mps1 accelerates mitosis. A similar
phenotype was reported for cells depleted of Mad2 or BubR1 [40].
The regulation of mitotic timing by Mad2 and BubR1 is
kinetochore-independent, since Mad1 depletion, while disabling
the mitotic checkpoint, did not affect normal mitotic timing [40].
It is therefore unlikely that lack of recruitment of Mad1 and Mad2
to kinetochores in Mps1-inhibited cells contributes to accelerated
mitosis. An explanation for the timing phenotype, proposed by
Meraldi et al., and in agreement with experimental data [41], is
the possibility that sufficient MCC exists in interphase to constrain
APC/C activity long enough to allow full chromosome biorienta-
tion in the majority of cells. In this model, only presence of
persistent unattached kinetochores requires additional MCC
formation to further prolong mitosis. Given the timing phenotype
of Mps1-inhibited cells, it is therefore possible that Mps1, in
addition to influencing Mad1-dependent MCC formation, affects
stability or inhibitory potential of pre-assembled MCC. Further
studies are needed to examine this hypothesis.
Due to its central role in mitosis, Mps1 is an attractive target for
anti-cancer therapies. A recent study from our lab proposed that
elevating the frequency of chromosome segregation errors by
partial Mps1 reduction can be of clinical relevance, especially with
other treatments that affect fidelity of chromosome segregation
[17]. We show here for the first time that specific inhibition of
Mps1 enzymatic activity efficiently kills human cells. Moreover, a
short pulse of inhibition followed by recovery caused lethality in a
significant fraction of cells. As such a pulse of Mps1 inhibition is
more relevant to potential future clinical situations than potent,
long-term kinase inhibition, these data illustrate that specific and
penetrant inhibition of Mps1 activity might indeed be a promising
anti-cancer strategy.
Materials and Methods
Tissue Culture and Treatments
UTR-Mps1
WT, UTR-Mps1
as, HCT-Mps1
WT and HCT-
Mps1
as cells were derived from UTRM10 [11,16,17] and HCT-
TRM (named HCT-116-TetRMps1 clone#2 in Ref. [17]) cell
lines, respectively. Briefly, these cell lines stably express TetR and
carry pSuperior-retro-puro-Mps1, resulting in depletion of Mps1
protein upon addition of doxycycline. To generate the derivative
cell lines that express Mps1
WT and Mps1
as, UTRM10 and HCT-
TRM cells were transfected using the calcium phosphate method
with the different LAP-Mps1 alleles and selected with doxycycline
(1 mg/ml). Single colonies were selected after limiting dilution.
HCT-TRM-derivative cells were grown in RPMI (Lonza) with 6%
Tet-approved FCS (Clontech), supplemented with pen/strep
(Invitrogen). UTRM10-derivative cells were grown in DMEM
(Lonza) with 8% Tet-approved FCS (Clontech), supplemented
with pen/strep (Invitrogen) and Ultra-Glutamine (Lonza).
Thymidine (2.5 mM), nocodazole (660 nM), taxol (1 mM),
MG132 (10 mM), monastrol (200 mM), STLC (10 mM), doxycy-
cline and puromycin (1 mgNml
21) were all from Sigma, ZM447449
(Tocris Bioscience) was added at 2 mM and 23dMB-PP1 at 1 mM.
Antibodies
The following primary antibodies were used for immunoblotting,
immunofluorescence imaging and FACS analyses: Mps1-NT
(Upstate), pT676-Mps1 [16], BubR1-300A (Bethyl), Mad2 (custom
polyclonal Rb antibody. Briefly, His6-Mad2 (pQE80L-hMad2) was
expressed in BL21 cells, purified using Ni-agarose (Qiagen) and
injected into New Zealand rabbits (Covance). Mad2 antibody was
affinity purified from rabbit serum using His6-Mad2), Bub1 (Abcam),
Mad1 (SantaCruz Biotechnology), a-tubulin (Sigma), CREST
(Cortex Biochem), MPM2 (Upstate), Cdc20 (SantaCruz Biotechnol-
ogy), Bub3 (BD Trans Lab) and Borealin (a gift of W. Earnshaw).
Secondary antibodies included anti-human Alexafluor647 and anti-
rabbit Alexafluor488 (Molecular Probes) for immunofluorescence
studies, anti-mouse-Cy5 (Jackson) for FACS and anti-Mouse/Rabbit
Alexa680/800 (Molecular Probes) for immunoblotting.
Flow cytometry
HCT- and UTR-derived cell lines were released from a
24 hours thymidine block into nocodazole or 23dMB-PP1 or a
combination of both for 18 hours, harvested and fixed in 70% ice-
cold ethanol for 24 hours, and analyzed using MPM2 immuno-
stains as described [42].
Immunofluorescence and live cell imaging
For immunolocalization studies, cells were plated on 12 mm
coverslips, pre-extracted with 0.2% TritonX-100 in warm PEM
(100 mM PIPES pH6.8, 1mM MgCl2 and 5mM EGTA) for
1 minute, fixed with 3% PFA in PBS, blocked with 3% BSA in
PBS for 1 hour, incubated with primary antibody for 16 hrs at
4uC, washed with PBS/0.1% TritonX-100 and incubated with
secondary antibodies for an additional 1 hour at room tempera-
ture. Coverslips were washed and submerged in PBS containing
DAPI, washed again and mounted using ProLong Antifade
(Molecular Probes). All images were acquired on a DeltaVision
RT system (Applied Precision) with a 100X/1.40NA UPlanSApo
objective (Olympus) using SoftWorx software. Images are
maximum intensity projections of deconvolved stacks. For
quantification, all images of similarly stained experiments and
acquired with identical illumination-settings were analyzed using
ImageJ. Average pixel intensities of the total of all regions
encompassing centromeres plus kinetochores were determined in
the various channels and corrected for background.
For live cell imaging, cells were plated in 4-well chambered
glass-bottom slides (LabTekII) or 24-well glass bottom plates
(MatTek), transfected and imaged in a heated chamber (37uC and
5% CO2) using a 20X/0.5NA UPLFLN objective on a Olympus
IX-81 microscope, controlled by Cell-M software (Olympus). 16
bits DIC (5 msec exposure) images were acquired every 2 minutes
using a Hamamatsu ORCA-ER camera. Images were processed
using Cell-M software.
Immunoprecipitation
HCT-Mps1
as cells were released from a 24 hours thymidine
block into nocodazole for 18 hours, harvested and lysed in 50 mM
Tris 7.5, 150 mM NaCl, 1% TX-100, 2 mM MgCl2, 5 mM
EDTA, supplemented with protease inhibitors and phosphatase
inhibitors for 10 minutes on ice. The cleared extract was
incubated with 10% protein A-agarose beads (Roche)/antibody
mix for 2 hours at 4uC on a rotating wheel. The beads were
washed twice with lysis buffer. Supernatant and beads were
processed for SDS-PAGE and the proteins were transferred to
nitrocellulose membranes for immunoblotting.
Colony Formation Assays
Cells (50,000/well) were plated in 6-well plates (Costar). Cells
were grown in media supplemented with DMSO or 23dMB-PP1
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continued incubation in media without 23dMB-PP1 for an
additional 6 days. At day 8, plates were washed with PBS, fixed
for 5 minutes with 96% methanol and stained with 0.1% crystal
violet in water for 30 minutes.
Supporting Information
Figure S1 A: Quantification of flow cytometric analysis of
fraction of mitotic cells treated with nocodazole for 18 hours. Cells
were transiently transfected with indicated LAP-Mps1 constructs.
D664A is an enzymatically inactive mutant. B: Box-and-whisker
diagrams of time spent in mitosis of UTR-Mps1as cell treated with
taxol in combination with increasing concentrations of different
bulky PP1 inhibitors. ND; not determined. (Molecular structures
displayed in right panel.)
Found at: doi:10.1371/journal.pone.0010251.s001 (0.27 MB TIF)
Figure S2 A: pT676-Mps1 and Mps1 immunoblot of UTR-
Mps1WT, UTR-Mps1as and UTR-Mps1M602G cells treated
with thymidine (thy) for 20 hours or with taxol and MG132 in
combination with indicated inhibitors for 1 hour. 1NM, 1NM-
PP1; 3MB, 3MB-PP1; SP, SP600125. B: Quantification of flow
cytometric analysis of fraction of mitotic UTRM10, UTR-
Mps1WT, UTR-Mps1as and UTR-Mps1M602G cells treated
with taxol in combination with indicated inhibitors for 17 hours.
C: Chromosome alignment in UTRM10, UTR-Mps1WT, UTR-
Mps1as and UTR-Mps1M602G cells treated with MG132 for
50 minutes in combination with the indicated inhibitors. Graph
displays percentages of cells with misaligned chromosomes.
Found at: doi:10.1371/journal.pone.0010251.s002 (0.84 MB TIF)
Figure S3 A–C: Time-lapse analysis by DIC microscopy of
HCT- and UTR-derived cells treated with (A) taxol (HCT-derived
cells) or STLC (UTR-derived cells) in combination with DMSO or
23dMB-PP1, or nocodazole (B, C) in combination with DMSO or
23dMB-PP1. Graphs in A display the time from NEB to the first
signs of furrow ingression for individual cells. Black bars indicate
end of time-lapse acquisition. Line graphs in B and C show
cumulative percentages of UTR-derived cells (B) and HCT-
derived cells (C) displaying first signs of furrowing at indicated
times after NEB.
Found at: doi:10.1371/journal.pone.0010251.s003 (0.79 MB TIF)
Figure S4 Immunolocalization of Mad1, Mad2, Bub1, BubR1,
Cdc20 and CENP-E and centromeres (ACA) in HCT-Mps1WT
(A) and UTR-Mps1WT (B) cells treated with nocodazole and
MG132 for 1 hour in combination with DMSO or 23dMB-PP1.
Graphs represent quantifications of kinetochore signal intensities
for the investigated proteins at all kinetochores in a single cell as a
ratio of the ACA signal. Data are average of three experiments, 10
cells per experiment (6SD). Representative images are shown.
DNA (DAPI) is in blue.
Found at: doi:10.1371/journal.pone.0010251.s004 (3.76 MB TIF)
Figure S5 Immunoblots of the indicated proteins in lysates of
the HCT- and UTR-Mps1 variant cell lines. Cells were treated
with thymidine (thy), or with the indicated inhibitors for 1 hour
followed by taxol/MG132 treatment for an additional 2 hrs. ZM,
ZM447439.
Found at: doi:10.1371/journal.pone.0010251.s005 (0.71 MB TIF)
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